Physician profile
Bernard Adami
NPI 1952491722
$864.59
in general payments reported to CMS, 2019-2025
14 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $55.99 · 2021: $205 · 2022: $122 · 2023: $105 · 2024: $114 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $249.33 | 2020-2024 | Slynd |
| Astellas Pharma US INC | $137.74 | 2023-2025 | Veozah |
| Amag Pharmaceuticals, INC. | $77.27 | 2019-2021 | |
| Organon LLC | $69.67 | 2021-2024 | |
| Avion Pharmaceuticals | $47.61 | 2022-2023 | Balcoltra |
| Heron Therapeutics, INC. | $47.09 | 2024 | Zynrelef |
| Hologic Sales and Service, LLC | $44.38 | 2021 | |
| Agile Therapeutics, INC. | $43.46 | 2021-2022 | |
| Mission Pharmacal Company | $41.20 | 2019 | |
| Abbvie INC. | $27.27 | 2023 | Lo Loestrin Fe, Orilissa |
| Exact Sciences Corporation | $24.59 | 2025 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $21.84 | 2019 | |
| Sumitomo Pharma America, INC. | $18.74 | 2024 | Myfembree |
| Millicent US INC | $14.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Adami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.